Rocket One Inc. Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2021-09-30 was $124.00K, a 81.24% decline year-over-year.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2020-12-31 was $36.84K, a 98.16% decline year-over-year.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2020-09-30 was $661.13K, a 219.76% increase year-over-year.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for the quarter ending 2020-06-30 was $16.08K, a 81.59% decline year-over-year.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2020 was $737.75K, a 70.43% decline from fiscal 2019.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2019 was $2.50M, a 1644.26% increase from fiscal 2018.
- Rocket One Inc. shares issued, value, share-based payment arrangement, before forfeiture for fiscal 2018 was $143.05K.
| Period end | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 3 month | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture 12 month |
|---|---|---|
| 2021-09-30 | $124.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $36.84K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $737.75K 10-K · filed 2021-03-16 |
| 2020-09-30 | $661.13K 10-Q · filed 2020-11-10 | $2.70M derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-06-30 | $16.08K 10-Q · filed 2020-08-13 | $2.24M derived: sum of 4 quarters · filed 2021-03-16 |
| 2020-03-31 | $23.70K 10-Q · filed 2020-05-13 | $2.32M derived: sum of 4 quarters · filed 2021-03-16 |
| 2019-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $2.50M 10-K · filed 2021-03-16 |
| 2019-09-30 | $206.76K 10-Q · filed 2020-11-10 | $501.80K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $87.37K 10-Q · filed 2020-08-13 | $300.63K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $202.71K 10-Q · filed 2020-05-13 | $330.76K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $4.96K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $143.05K 10-K · filed 2020-03-02 |
| 2018-09-30 | $5.59K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $117.50K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $15.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |